1. To describe the progression of heart failure in metabolic terms.
2. Evaluate treatments for diabetes in heart failure in the context of heart failure stages.
3. Become familiar with CV outcomes observed in recent trials of therapies for Type-2 Diabetes.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation